Evaluation of the use of CGRP monoclonal antibodies (mAbs) in migraine prophylaxis in a private clinic. Headache Medicine, [S. l.], v. 14, n. 2, p. 83–88, 2023. DOI: 10.48208/HeadacheMed.2023.17. Disponível em: https://headachemedicine.com.br/hm/article/view/747. Acesso em: 22 jan. 2026.